ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Longevity and Anti-Aging Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-36U14692
Home | Market Reports | Beauty & Fitness
Global Longevity and Anti Aging Drugs Market Insights Forecast to 2029
BUY CHAPTERS

Global Longevity and Anti-Aging Drugs Market Research Report 2025

Code: QYRE-Auto-36U14692
Report
February 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vitality Pro
MoleQlar
Hansen Supplements
Supplement Place
Maxx Herb
Youth & Earth
Rejuvant LifeTabs
Renue By Science
Double Wood Supplements
Quicksilver Scientific
California Gold Nutrition
ProHealth Longevity
Peak Performance
Do Not Age
Nutriop
AFEGA Anti-Aging-Shop
Xi'an Angel Biotechnology Co., Ltd.
Longevity Box
Age Science
Nutravita
Aeternum
Toniiq
ProNutrition
Genex Formulas
Physicians Longevity
AlphaFit
Lovita Foods
Jarrow Formulas
Body Union

Longevity and Anti-Aging Drugs Market Size

The global market for Longevity and Anti-Aging Drugs was valued at US$ 17140 million in the year 2024 and is projected to reach a revised size of US$ 37260 million by 2031, growing at a CAGR of 11.9% during the forecast period.

Longevity and Anti-Aging Drugs Market

Longevity and Anti-Aging Drugs Market

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Longevity and Anti-Aging Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Longevity and Anti-Aging Drugs.
The Longevity and Anti-Aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Longevity and Anti-Aging Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Longevity and Anti-Aging Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Longevity and Anti-Aging Drugs Market Report

Report Metric Details
Report Name Longevity and Anti-Aging Drugs Market
Accounted market size in year US$ 17140 million
Forecasted market size in 2031 US$ 37260 million
CAGR 11.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Adult Male (Under 60 Years Old)
  • Adult Female (Under 60 Years Old)
  • Elderly (Above 60 Years Old)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science, Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Peak Performance, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Xi'an Angel Biotechnology Co., Ltd., Longevity Box, Age Science, Nutravita, Aeternum, Toniiq, ProNutrition, Genex Formulas, Physicians Longevity, AlphaFit, Lovita Foods, Jarrow Formulas, Body Union
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Longevity and Anti-Aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Longevity and Anti-Aging Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Longevity and Anti-Aging Drugs Market growing?

Ans: The Longevity and Anti-Aging Drugs Market witnessing a CAGR of 11.9% during the forecast period 2025-2031.

What is the Longevity and Anti-Aging Drugs Market size in 2031?

Ans: The Longevity and Anti-Aging Drugs Market size in 2031 will be US$ 37260 million.

Who are the main players in the Longevity and Anti-Aging Drugs Market report?

Ans: The main players in the Longevity and Anti-Aging Drugs Market are Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science, Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Peak Performance, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Xi'an Angel Biotechnology Co., Ltd., Longevity Box, Age Science, Nutravita, Aeternum, Toniiq, ProNutrition, Genex Formulas, Physicians Longevity, AlphaFit, Lovita Foods, Jarrow Formulas, Body Union

What are the Application segmentation covered in the Longevity and Anti-Aging Drugs Market report?

Ans: The Applications covered in the Longevity and Anti-Aging Drugs Market report are Adult Male (Under 60 Years Old), Adult Female (Under 60 Years Old), Elderly (Above 60 Years Old)

What are the Type segmentation covered in the Longevity and Anti-Aging Drugs Market report?

Ans: The Types covered in the Longevity and Anti-Aging Drugs Market report are Calcium AKG Supplement, Nicotinamide Mononucleotide Supplement, Others

Recommended Reports

Neurodegenerative Diseases

Anti-Aging Therapies

Chronic Disease Drugs

1 Longevity and Anti-Aging Drugs Market Overview
1.1 Product Definition
1.2 Longevity and Anti-Aging Drugs by Type
1.2.1 Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Calcium AKG Supplement
1.2.3 Nicotinamide Mononucleotide Supplement
1.2.4 Others
1.3 Longevity and Anti-Aging Drugs by Application
1.3.1 Global Longevity and Anti-Aging Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adult Male (Under 60 Years Old)
1.3.3 Adult Female (Under 60 Years Old)
1.3.4 Elderly (Above 60 Years Old)
1.4 Global Longevity and Anti-Aging Drugs Market Size Estimates and Forecasts
1.4.1 Global Longevity and Anti-Aging Drugs Revenue 2020-2031
1.4.2 Global Longevity and Anti-Aging Drugs Sales 2020-2031
1.4.3 Global Longevity and Anti-Aging Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Longevity and Anti-Aging Drugs Market Competition by Manufacturers
2.1 Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Longevity and Anti-Aging Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Longevity and Anti-Aging Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Product Type & Application
2.7 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Date of Enter into This Industry
2.8 Global Longevity and Anti-Aging Drugs Market Competitive Situation and Trends
2.8.1 Global Longevity and Anti-Aging Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Longevity and Anti-Aging Drugs Players Market Share by Revenue
2.8.3 Global Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Longevity and Anti-Aging Drugs Market Scenario by Region
3.1 Global Longevity and Anti-Aging Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Longevity and Anti-Aging Drugs Sales by Region: 2020-2031
3.2.1 Global Longevity and Anti-Aging Drugs Sales by Region: 2020-2025
3.2.2 Global Longevity and Anti-Aging Drugs Sales by Region: 2026-2031
3.3 Global Longevity and Anti-Aging Drugs Revenue by Region: 2020-2031
3.3.1 Global Longevity and Anti-Aging Drugs Revenue by Region: 2020-2025
3.3.2 Global Longevity and Anti-Aging Drugs Revenue by Region: 2026-2031
3.4 North America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.4.1 North America Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.4.3 North America Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.5.1 Europe Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.5.3 Europe Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Longevity and Anti-Aging Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.7.1 Latin America Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.7.3 Latin America Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Longevity and Anti-Aging Drugs Sales by Type (2020-2031)
4.1.1 Global Longevity and Anti-Aging Drugs Sales by Type (2020-2025)
4.1.2 Global Longevity and Anti-Aging Drugs Sales by Type (2026-2031)
4.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2020-2031)
4.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2020-2031)
4.2.1 Global Longevity and Anti-Aging Drugs Revenue by Type (2020-2025)
4.2.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2026-2031)
4.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Longevity and Anti-Aging Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Longevity and Anti-Aging Drugs Sales by Application (2020-2031)
5.1.1 Global Longevity and Anti-Aging Drugs Sales by Application (2020-2025)
5.1.2 Global Longevity and Anti-Aging Drugs Sales by Application (2026-2031)
5.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2020-2031)
5.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2020-2031)
5.2.1 Global Longevity and Anti-Aging Drugs Revenue by Application (2020-2025)
5.2.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2026-2031)
5.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Longevity and Anti-Aging Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Vitality Pro
6.1.1 Vitality Pro Company Information
6.1.2 Vitality Pro Description and Business Overview
6.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Vitality Pro Longevity and Anti-Aging Drugs Product Portfolio
6.1.5 Vitality Pro Recent Developments/Updates
6.2 MoleQlar
6.2.1 MoleQlar Company Information
6.2.2 MoleQlar Description and Business Overview
6.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MoleQlar Longevity and Anti-Aging Drugs Product Portfolio
6.2.5 MoleQlar Recent Developments/Updates
6.3 Hansen Supplements
6.3.1 Hansen Supplements Company Information
6.3.2 Hansen Supplements Description and Business Overview
6.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.3.5 Hansen Supplements Recent Developments/Updates
6.4 Supplement Place
6.4.1 Supplement Place Company Information
6.4.2 Supplement Place Description and Business Overview
6.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Supplement Place Longevity and Anti-Aging Drugs Product Portfolio
6.4.5 Supplement Place Recent Developments/Updates
6.5 Maxx Herb
6.5.1 Maxx Herb Company Information
6.5.2 Maxx Herb Description and Business Overview
6.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Maxx Herb Longevity and Anti-Aging Drugs Product Portfolio
6.5.5 Maxx Herb Recent Developments/Updates
6.6 Youth & Earth
6.6.1 Youth & Earth Company Information
6.6.2 Youth & Earth Description and Business Overview
6.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Youth & Earth Longevity and Anti-Aging Drugs Product Portfolio
6.6.5 Youth & Earth Recent Developments/Updates
6.7 Rejuvant LifeTabs
6.7.1 Rejuvant LifeTabs Company Information
6.7.2 Rejuvant LifeTabs Description and Business Overview
6.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Portfolio
6.7.5 Rejuvant LifeTabs Recent Developments/Updates
6.8 Renue By Science
6.8.1 Renue By Science Company Information
6.8.2 Renue By Science Description and Business Overview
6.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Renue By Science Longevity and Anti-Aging Drugs Product Portfolio
6.8.5 Renue By Science Recent Developments/Updates
6.9 Double Wood Supplements
6.9.1 Double Wood Supplements Company Information
6.9.2 Double Wood Supplements Description and Business Overview
6.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.9.5 Double Wood Supplements Recent Developments/Updates
6.10 Quicksilver Scientific
6.10.1 Quicksilver Scientific Company Information
6.10.2 Quicksilver Scientific Description and Business Overview
6.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Portfolio
6.10.5 Quicksilver Scientific Recent Developments/Updates
6.11 California Gold Nutrition
6.11.1 California Gold Nutrition Company Information
6.11.2 California Gold Nutrition Description and Business Overview
6.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Product Portfolio
6.11.5 California Gold Nutrition Recent Developments/Updates
6.12 ProHealth Longevity
6.12.1 ProHealth Longevity Company Information
6.12.2 ProHealth Longevity Description and Business Overview
6.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.12.5 ProHealth Longevity Recent Developments/Updates
6.13 Peak Performance
6.13.1 Peak Performance Company Information
6.13.2 Peak Performance Description and Business Overview
6.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Peak Performance Longevity and Anti-Aging Drugs Product Portfolio
6.13.5 Peak Performance Recent Developments/Updates
6.14 Do Not Age
6.14.1 Do Not Age Company Information
6.14.2 Do Not Age Description and Business Overview
6.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Do Not Age Longevity and Anti-Aging Drugs Product Portfolio
6.14.5 Do Not Age Recent Developments/Updates
6.15 Nutriop
6.15.1 Nutriop Company Information
6.15.2 Nutriop Description and Business Overview
6.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nutriop Longevity and Anti-Aging Drugs Product Portfolio
6.15.5 Nutriop Recent Developments/Updates
6.16 AFEGA Anti-Aging-Shop
6.16.1 AFEGA Anti-Aging-Shop Company Information
6.16.2 AFEGA Anti-Aging-Shop Description and Business Overview
6.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Portfolio
6.16.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
6.17 Xi'an Angel Biotechnology Co., Ltd.
6.17.1 Xi'an Angel Biotechnology Co., Ltd. Company Information
6.17.2 Xi'an Angel Biotechnology Co., Ltd. Description and Business Overview
6.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Portfolio
6.17.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
6.18 Longevity Box
6.18.1 Longevity Box Company Information
6.18.2 Longevity Box Description and Business Overview
6.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Longevity Box Longevity and Anti-Aging Drugs Product Portfolio
6.18.5 Longevity Box Recent Developments/Updates
6.19 Age Science
6.19.1 Age Science Company Information
6.19.2 Age Science Description and Business Overview
6.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Age Science Longevity and Anti-Aging Drugs Product Portfolio
6.19.5 Age Science Recent Developments/Updates
6.20 Nutravita
6.20.1 Nutravita Company Information
6.20.2 Nutravita Description and Business Overview
6.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Nutravita Longevity and Anti-Aging Drugs Product Portfolio
6.20.5 Nutravita Recent Developments/Updates
6.21 Aeternum
6.21.1 Aeternum Company Information
6.21.2 Aeternum Description and Business Overview
6.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Aeternum Longevity and Anti-Aging Drugs Product Portfolio
6.21.5 Aeternum Recent Developments/Updates
6.22 Toniiq
6.22.1 Toniiq Company Information
6.22.2 Toniiq Description and Business Overview
6.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Toniiq Longevity and Anti-Aging Drugs Product Portfolio
6.22.5 Toniiq Recent Developments/Updates
6.23 ProNutrition
6.23.1 ProNutrition Company Information
6.23.2 ProNutrition Description and Business Overview
6.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 ProNutrition Longevity and Anti-Aging Drugs Product Portfolio
6.23.5 ProNutrition Recent Developments/Updates
6.24 Genex Formulas
6.24.1 Genex Formulas Company Information
6.24.2 Genex Formulas Description and Business Overview
6.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Genex Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.24.5 Genex Formulas Recent Developments/Updates
6.25 Physicians Longevity
6.25.1 Physicians Longevity Company Information
6.25.2 Physicians Longevity Description and Business Overview
6.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.25.5 Physicians Longevity Recent Developments/Updates
6.26 AlphaFit
6.26.1 AlphaFit Company Information
6.26.2 AlphaFit Description and Business Overview
6.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.26.4 AlphaFit Longevity and Anti-Aging Drugs Product Portfolio
6.26.5 AlphaFit Recent Developments/Updates
6.27 Lovita Foods
6.27.1 Lovita Foods Company Information
6.27.2 Lovita Foods Description and Business Overview
6.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Lovita Foods Longevity and Anti-Aging Drugs Product Portfolio
6.27.5 Lovita Foods Recent Developments/Updates
6.28 Jarrow Formulas
6.28.1 Jarrow Formulas Company Information
6.28.2 Jarrow Formulas Description and Business Overview
6.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.28.5 Jarrow Formulas Recent Developments/Updates
6.29 Body Union
6.29.1 Body Union Company Information
6.29.2 Body Union Description and Business Overview
6.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Body Union Longevity and Anti-Aging Drugs Product Portfolio
6.29.5 Body Union Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Longevity and Anti-Aging Drugs Industry Chain Analysis
7.2 Longevity and Anti-Aging Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Longevity and Anti-Aging Drugs Production Mode & Process Analysis
7.4 Longevity and Anti-Aging Drugs Sales and Marketing
7.4.1 Longevity and Anti-Aging Drugs Sales Channels
7.4.2 Longevity and Anti-Aging Drugs Distributors
7.5 Longevity and Anti-Aging Drugs Customer Analysis
8 Longevity and Anti-Aging Drugs Market Dynamics
8.1 Longevity and Anti-Aging Drugs Industry Trends
8.2 Longevity and Anti-Aging Drugs Market Drivers
8.3 Longevity and Anti-Aging Drugs Market Challenges
8.4 Longevity and Anti-Aging Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Vitality Pro
MoleQlar
Hansen Supplements
Supplement Place
Maxx Herb
Youth & Earth
Rejuvant LifeTabs
Renue By Science
Double Wood Supplements
Quicksilver Scientific
California Gold Nutrition
ProHealth Longevity
Peak Performance
Do Not Age
Nutriop
AFEGA Anti-Aging-Shop
Xi'an Angel Biotechnology Co., Ltd.
Longevity Box
Age Science
Nutravita
Aeternum
Toniiq
ProNutrition
Genex Formulas
Physicians Longevity
AlphaFit
Lovita Foods
Jarrow Formulas
Body Union
List of Tables
 Table 1. Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Longevity and Anti-Aging Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Longevity and Anti-Aging Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Longevity and Anti-Aging Drugs Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Longevity and Anti-Aging Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Longevity and Anti-Aging Drugs Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Longevity and Anti-Aging Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Longevity and Anti-Aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-Aging Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Longevity and Anti-Aging Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Longevity and Anti-Aging Drugs Sales by Region (2020-2025) & (Tons)
 Table 18. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Longevity and Anti-Aging Drugs Sales by Region (2026-2031) & (Tons)
 Table 20. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Longevity and Anti-Aging Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Longevity and Anti-Aging Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Longevity and Anti-Aging Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Longevity and Anti-Aging Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Longevity and Anti-Aging Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Longevity and Anti-Aging Drugs Sales by Country (2020-2025) & (Tons)
 Table 27. North America Longevity and Anti-Aging Drugs Sales by Country (2026-2031) & (Tons)
 Table 28. North America Longevity and Anti-Aging Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Longevity and Anti-Aging Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Longevity and Anti-Aging Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Longevity and Anti-Aging Drugs Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Longevity and Anti-Aging Drugs Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Longevity and Anti-Aging Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Longevity and Anti-Aging Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Longevity and Anti-Aging Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Longevity and Anti-Aging Drugs Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Longevity and Anti-Aging Drugs Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Longevity and Anti-Aging Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Longevity and Anti-Aging Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Longevity and Anti-Aging Drugs Sales (Tons) by Type (2020-2025)
 Table 51. Global Longevity and Anti-Aging Drugs Sales (Tons) by Type (2026-2031)
 Table 52. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Longevity and Anti-Aging Drugs Sales (Tons) by Application (2020-2025)
 Table 61. Global Longevity and Anti-Aging Drugs Sales (Tons) by Application (2026-2031)
 Table 62. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2026-2031)
 Table 70. Vitality Pro Company Information
 Table 71. Vitality Pro Description and Business Overview
 Table 72. Vitality Pro Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Vitality Pro Longevity and Anti-Aging Drugs Product
 Table 74. Vitality Pro Recent Developments/Updates
 Table 75. MoleQlar Company Information
 Table 76. MoleQlar Description and Business Overview
 Table 77. MoleQlar Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. MoleQlar Longevity and Anti-Aging Drugs Product
 Table 79. MoleQlar Recent Developments/Updates
 Table 80. Hansen Supplements Company Information
 Table 81. Hansen Supplements Description and Business Overview
 Table 82. Hansen Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Hansen Supplements Longevity and Anti-Aging Drugs Product
 Table 84. Hansen Supplements Recent Developments/Updates
 Table 85. Supplement Place Company Information
 Table 86. Supplement Place Description and Business Overview
 Table 87. Supplement Place Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Supplement Place Longevity and Anti-Aging Drugs Product
 Table 89. Supplement Place Recent Developments/Updates
 Table 90. Maxx Herb Company Information
 Table 91. Maxx Herb Description and Business Overview
 Table 92. Maxx Herb Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Maxx Herb Longevity and Anti-Aging Drugs Product
 Table 94. Maxx Herb Recent Developments/Updates
 Table 95. Youth & Earth Company Information
 Table 96. Youth & Earth Description and Business Overview
 Table 97. Youth & Earth Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Youth & Earth Longevity and Anti-Aging Drugs Product
 Table 99. Youth & Earth Recent Developments/Updates
 Table 100. Rejuvant LifeTabs Company Information
 Table 101. Rejuvant LifeTabs Description and Business Overview
 Table 102. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product
 Table 104. Rejuvant LifeTabs Recent Developments/Updates
 Table 105. Renue By Science Company Information
 Table 106. Renue By Science Description and Business Overview
 Table 107. Renue By Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Renue By Science Longevity and Anti-Aging Drugs Product
 Table 109. Renue By Science Recent Developments/Updates
 Table 110. Double Wood Supplements Company Information
 Table 111. Double Wood Supplements Description and Business Overview
 Table 112. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Double Wood Supplements Longevity and Anti-Aging Drugs Product
 Table 114. Double Wood Supplements Recent Developments/Updates
 Table 115. Quicksilver Scientific Company Information
 Table 116. Quicksilver Scientific Description and Business Overview
 Table 117. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Quicksilver Scientific Longevity and Anti-Aging Drugs Product
 Table 119. Quicksilver Scientific Recent Developments/Updates
 Table 120. California Gold Nutrition Company Information
 Table 121. California Gold Nutrition Description and Business Overview
 Table 122. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. California Gold Nutrition Longevity and Anti-Aging Drugs Product
 Table 124. California Gold Nutrition Recent Developments/Updates
 Table 125. ProHealth Longevity Company Information
 Table 126. ProHealth Longevity Description and Business Overview
 Table 127. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. ProHealth Longevity Longevity and Anti-Aging Drugs Product
 Table 129. ProHealth Longevity Recent Developments/Updates
 Table 130. Peak Performance Company Information
 Table 131. Peak Performance Description and Business Overview
 Table 132. Peak Performance Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Peak Performance Longevity and Anti-Aging Drugs Product
 Table 134. Peak Performance Recent Developments/Updates
 Table 135. Do Not Age Company Information
 Table 136. Do Not Age Description and Business Overview
 Table 137. Do Not Age Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Do Not Age Longevity and Anti-Aging Drugs Product
 Table 139. Do Not Age Recent Developments/Updates
 Table 140. Nutriop Company Information
 Table 141. Nutriop Description and Business Overview
 Table 142. Nutriop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. Nutriop Longevity and Anti-Aging Drugs Product
 Table 144. Nutriop Recent Developments/Updates
 Table 145. AFEGA Anti-Aging-Shop Company Information
 Table 146. AFEGA Anti-Aging-Shop Description and Business Overview
 Table 147. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product
 Table 149. AFEGA Anti-Aging-Shop Recent Developments/Updates
 Table 150. Xi'an Angel Biotechnology Co., Ltd. Company Information
 Table 151. Xi'an Angel Biotechnology Co., Ltd. Description and Business Overview
 Table 152. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 153. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product
 Table 154. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
 Table 155. Longevity Box Company Information
 Table 156. Longevity Box Description and Business Overview
 Table 157. Longevity Box Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 158. Longevity Box Longevity and Anti-Aging Drugs Product
 Table 159. Longevity Box Recent Developments/Updates
 Table 160. Age Science Company Information
 Table 161. Age Science Description and Business Overview
 Table 162. Age Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 163. Age Science Longevity and Anti-Aging Drugs Product
 Table 164. Age Science Recent Developments/Updates
 Table 165. Nutravita Company Information
 Table 166. Nutravita Description and Business Overview
 Table 167. Nutravita Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 168. Nutravita Longevity and Anti-Aging Drugs Product
 Table 169. Nutravita Recent Developments/Updates
 Table 170. Aeternum Company Information
 Table 171. Aeternum Description and Business Overview
 Table 172. Aeternum Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 173. Aeternum Longevity and Anti-Aging Drugs Product
 Table 174. Aeternum Recent Developments/Updates
 Table 175. Toniiq Company Information
 Table 176. Toniiq Description and Business Overview
 Table 177. Toniiq Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 178. Toniiq Longevity and Anti-Aging Drugs Product
 Table 179. Toniiq Recent Developments/Updates
 Table 180. ProNutrition Company Information
 Table 181. ProNutrition Description and Business Overview
 Table 182. ProNutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 183. ProNutrition Longevity and Anti-Aging Drugs Product
 Table 184. ProNutrition Recent Developments/Updates
 Table 185. Genex Formulas Company Information
 Table 186. Genex Formulas Description and Business Overview
 Table 187. Genex Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 188. Genex Formulas Longevity and Anti-Aging Drugs Product
 Table 189. Genex Formulas Recent Developments/Updates
 Table 190. Physicians Longevity Company Information
 Table 191. Physicians Longevity Description and Business Overview
 Table 192. Physicians Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 193. Physicians Longevity Longevity and Anti-Aging Drugs Product
 Table 194. Physicians Longevity Recent Developments/Updates
 Table 195. AlphaFit Company Information
 Table 196. AlphaFit Description and Business Overview
 Table 197. AlphaFit Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 198. AlphaFit Longevity and Anti-Aging Drugs Product
 Table 199. AlphaFit Recent Developments/Updates
 Table 200. Lovita Foods Company Information
 Table 201. Lovita Foods Description and Business Overview
 Table 202. Lovita Foods Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 203. Lovita Foods Longevity and Anti-Aging Drugs Product
 Table 204. Lovita Foods Recent Developments/Updates
 Table 205. Jarrow Formulas Company Information
 Table 206. Jarrow Formulas Description and Business Overview
 Table 207. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 208. Jarrow Formulas Longevity and Anti-Aging Drugs Product
 Table 209. Jarrow Formulas Recent Developments/Updates
 Table 210. Body Union Company Information
 Table 211. Body Union Description and Business Overview
 Table 212. Body Union Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 213. Body Union Longevity and Anti-Aging Drugs Product
 Table 214. Body Union Recent Developments/Updates
 Table 215. Key Raw Materials Lists
 Table 216. Raw Materials Key Suppliers Lists
 Table 217. Longevity and Anti-Aging Drugs Distributors List
 Table 218. Longevity and Anti-Aging Drugs Customers List
 Table 219. Longevity and Anti-Aging Drugs Market Trends
 Table 220. Longevity and Anti-Aging Drugs Market Drivers
 Table 221. Longevity and Anti-Aging Drugs Market Challenges
 Table 222. Longevity and Anti-Aging Drugs Market Restraints
 Table 223. Research Programs/Design for This Report
 Table 224. Key Data Information from Secondary Sources
 Table 225. Key Data Information from Primary Sources
 Table 226. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Longevity and Anti-Aging Drugs
 Figure 2. Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Longevity and Anti-Aging Drugs Market Share by Type: 2024 & 2031
 Figure 4. Calcium AKG Supplement Product Picture
 Figure 5. Nicotinamide Mononucleotide Supplement Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Longevity and Anti-Aging Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Longevity and Anti-Aging Drugs Market Share by Application: 2024 & 2031
 Figure 9. Adult Male (Under 60 Years Old)
 Figure 10. Adult Female (Under 60 Years Old)
 Figure 11. Elderly (Above 60 Years Old)
 Figure 12. Global Longevity and Anti-Aging Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Longevity and Anti-Aging Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Longevity and Anti-Aging Drugs Sales (2020-2031) & (Tons)
 Figure 15. Global Longevity and Anti-Aging Drugs Average Price (US$/Ton) & (2020-2031)
 Figure 16. Longevity and Anti-Aging Drugs Report Years Considered
 Figure 17. Longevity and Anti-Aging Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Longevity and Anti-Aging Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Longevity and Anti-Aging Drugs Players: Market Share by Revenue in Longevity and Anti-Aging Drugs in 2024
 Figure 20. Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Longevity and Anti-Aging Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Longevity and Anti-Aging Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Longevity and Anti-Aging Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Longevity and Anti-Aging Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Longevity and Anti-Aging Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Longevity and Anti-Aging Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Longevity and Anti-Aging Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Longevity and Anti-Aging Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Longevity and Anti-Aging Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Longevity and Anti-Aging Drugs by Type (2020-2031)
 Figure 56. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Longevity and Anti-Aging Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Longevity and Anti-Aging Drugs by Application (2020-2031)
 Figure 59. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2020-2031)
 Figure 60. Longevity and Anti-Aging Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Facial Injectables Market Research Report 2024
Anti aging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Botulinum Neurotoxin Dermal Fillers Market Research Report 2024
Global Anti aging Cosmetics Products Market Research Report 2024
Global Botox Hair Treatment Product Market Research Report 2024
Global Anti Aging Skincare Product Market Research Report 2024
Global Longevity and Anti senescence Therapy Market Insights Forecast to 2030
Global Dermal Fillers and Botulinum Toxin Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Skin Anti Aging Product Market Research Report 2025
Global Injectable Botulinum Toxin for Aesthetic Medicine Market Research Report 2024
Global Facial Wrinkle Filler Market Research Report 2025
Anti aging Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti aging Botox Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Aging Drugs and Devices Market Insights Forecast to 2030
Global Non Invasive Cosmetic Treatments Market Research Report 2024
Global Anti Senescence Therapy Market Insights Forecast to 2030
Global Anti aging Ingredients Market Insights Forecast to 2030
Anti Aging and Wrinkle Skincare Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti aging and Anti wrinkle Products Market Research Report 2024
Global Injectable Anti Wrinkle Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Head and Face Aesthetic Procedure Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T14057
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Fitness Equipment and Indoor Sports Centers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4P7038
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Fitness Business Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7O4235
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Facial Makeup Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7K8438
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions